Cord Blood America Hires Management Team for Its New Stem Cell Laboratory
SANTA MONICA, Calif. and LAS VEGAS, July 10 /PRNewswire-FirstCall/ -- Cord
Blood America, Inc. (OTC Bulletin Board: CBAI), one of the largest umbilical
cord blood stem cell preservation companies (http://www.cordblood-america.com)
focused on bringing the life saving potential of stem cells to families
nationwide and internationally, announced today it has hired famed
Immunologist Dr. Geoffrey John O'Neill as its new Laboratory Director and
Brian Pockett as Vice President of Laboratory Operations.
Cord Blood America recently announced it is opening a state-of-the-art
laboratory for the storage of multiple stem cell products, including umbilical
cord blood stem cells, in Las Vegas, Nevada.
"We are pleased that two such distinguished, experienced, successful
professionals will be overseeing our new lab," said Company founder and CEO
Matthew Schissler. "The lab will be used to process and store umbilical cord
blood stem cells, to store other forms of stem cells such as peripheral blood
stem cell and adipose tissues, and for research and product development."
Dr. O'Neill was Laboratory and Scientific/Medical Director for Cryo-Cell
International Inc. in Florida and was Laboratory Director for the Bio-Matrix
Scientific Group Inc., a San Diego biotech research and development firm in
the stem cell sector. He received a Ph.D. in Immunology from the University
of Glasgow, Scotland, and is the author or co-author of more than 75
publications in his field in which he has won a number of significant honors.
Mr. Pockett has more than 30 years professional experience in operations,
business development, marketing, sales and financial and grant development.
He has served as a consultant on global distribution, product development,
commercialization, investment and intellectual properties for some of the
largest companies in the U.S. He also served as Managing Director and Chief
Operating Officer for Bio-Matrix Scientific Group Inc.
Click here to view social media version of this release.
Click here to visit the Cord Blood America, Inc. Social Media Newsroom.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of
CorCell, which facilitates umbilical cord blood stem cell preservation for
expectant parents and their children. Its mission is to be the most respected
stem cell preservation company in the industry. Collected through a safe and
non-invasive process, cord blood stem cells offer a powerful and potentially
life-saving resource for treating a growing number of ailments, including
cancer, leukemia, blood, and immune disorders. To find out more about Cord
Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at
www.corcell.com. For investor information, visit www.cordblood-america.com.
Forward-Looking Statements
Some statements made in this press release are forward-looking statements,
which are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. We use words such as "anticipate,"
"believe," "expect," "future," "intend," "plan," and similar expressions to
identify forward-looking statements. These statements including those related
to the growth of the industry, new stem cell treatments, and the Company's
performance, are only predictions and are subject to certain risks,
uncertainties and assumptions. Additional risks are identified and described
in the Company's public filings with the Securities and Exchange Commission.
Statements made herein are as of the date of this press release and should not
be relied upon as of any subsequent date. The Company's past performance is
not necessarily indicative of its future performance. The Company does not
undertake, and the Company specifically disclaims any obligation to update any
forward-looking statements to reflect occurrences, developments, events, or
circumstances after the date of such statement.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
SOURCE Cord Blood America, Inc.
Paul Knopick of E & E Communications, +1-949-707-5365,
pknopick@eandecommunications.com, for Cord Blood America, Inc.
© Thomson Reuters 2009 All rights reserved



